Increased glomerular cytosolic phospholipase A2 activity of OLETF rats with early diabetes

被引:12
|
作者
Furuya, Y
Tagami, S
Hasegawa, A
Ishii, J
Hirokawa, J
Yoshimura, H
Honda, T
Sakaue, S
Aoki, K
Murakami, M
Kudo, I
Kawakami, Y
机构
[1] Hokkaido Univ, Sch Med, Dept Med 1, Kita Ku, Sapporo, Hokkaido 060, Japan
[2] Showa Univ, Sch Pharmaceut Sci, Dept Hlth Chem, Tokyo 142, Japan
关键词
cytosolic phospholipase A(2); diabetic nephropathy; glomeruli; hyperfiltration; OLETF rats;
D O I
10.1055/s-0029-1212116
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In view of the potential role of prostaglandins (PGs) in development of glomerular hyperfiltration leading to diabetic nephropathy, we studied the temporal relationship of the activity of cytosolic phospholipase A(2) (cPLA(2)), a rate-limiting enzyme for eicosanoid biosynthesis, with hyperfiltration and the histological changes in glomeruli using OLETF rats, a model for non-insulin-dependent diabetes mellitus (NIDDM). Diabetes mellitus and associated histopathological changes, which developed spontaneously by 30-46 weeks after birth of OLETF rats, were accompanied by approximately 65% increase in glomerular cPLA(2) activity that showed significant correlations with elevated plasma glucose levels and creatinine clearance. Moreover, mesangial cells cultured for 5 days with high glucose exhibited approximately 2-fold higher cPLA(2) activity than those cultured with physiologic level of glucose. These data suggest that increased glomerular cPLA(2) activity leads to production of PGs, which may promote the progression of early diabetic glomerular hyperfiltration and subsequent diabetic nephropathy.
引用
收藏
页码:299 / 305
页数:7
相关论文
共 50 条
  • [31] Lactosylceramide Interacts with and Activates Cytosolic Phospholipase A2α
    Nakamura, Hiroyuki
    Moriyama, Yuta
    Makiyama, Tomohiko
    Emori, Shunsuke
    Yamashita, Hisahiro
    Yamazaki, Risa
    Murayama, Toshihiko
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (32) : 23264 - 23272
  • [32] Localization and function of cytosolic phospholipase A2α at the Golgi
    Leslie, Christina C.
    Gangelhoff, Todd A.
    Gelb, Michael H.
    BIOCHIMIE, 2010, 92 (06) : 620 - 626
  • [33] Cytosolic phospholipase A2 as a target for drug design
    Lehr, M
    DRUGS OF THE FUTURE, 2000, 25 (08) : 823 - 832
  • [34] Cytosolic phospholipase A2 as a mediator of disease pathogenesis
    Linkous, Amanda
    Yazlovitskaya, Eugenia
    CELLULAR MICROBIOLOGY, 2010, 12 (10) : 1369 - 1377
  • [35] The role of cytosolic phospholipase A2 in insulin secretion
    Jones, PM
    Burns, CJ
    Belin, VD
    Roderigo-Milne, HM
    Persaud, SJ
    DIABETES, 2004, 53 : S172 - S178
  • [36] Nuclear membrane mechanotransduction by cytosolic phospholipase A2
    Niethammer, P.
    Shen, Z.
    Belcheva, K. T.
    Jelcic, M.
    Hui, K.
    Katikaneni, A.
    MOLECULAR BIOLOGY OF THE CELL, 2023, 34 (02) : 99 - 99
  • [37] Recent advances in the regulation of cytosolic phospholipase A2
    Gijon, MA
    Spencer, DM
    Leslie, CC
    ADVANCES IN ENZYME REGULATION, VOL 40, 2000, 40 : 255 - 268
  • [38] Pyrrolidine inhibitors of human cytosolic phospholipase A2
    Seno, K
    Okuno, T
    Nishi, K
    Murakami, Y
    Watanabe, F
    Matsuura, T
    Wada, M
    Fujii, Y
    Yamada, M
    Ogawa, T
    Okada, T
    Hashizume, H
    Kii, M
    Hara, S
    Hagishita, S
    Nakamoto, S
    Yamada, K
    Chikazawa, Y
    Ueno, M
    Teshirogi, I
    Ono, T
    Ohtani, M
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (06) : 1041 - 1044
  • [39] Cytosolic Phospholipase A2: A Drug Target in FSGS
    Erkan, Elif
    Chhaing, Richard
    Potter, Andrew
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 50 - 51
  • [40] Cytosolic Phospholipase A2 and Lysophospholipids in Tumor Angiogenesis
    Linkous, Amanda G.
    Yazlovitskaya, Eugenia M.
    Hallahan, Dennis E.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (18): : 1398 - 1412